Bristol-Myers Squibb Posts Upbeat Q2 Results, Lifts Profit Forecast

Loading...
Loading...
Bristol-Myers Squibb Co
BMY
reported stronger-than-expected earnings for the second quarter and raised its profit forecast for the full year. The New York-based company posted a quarterly loss of $130 million, or $0.08 per share, versus a year-ago profit of $333 million, or $0.20 per share. Excluding special items, the company earned $0.53 per share. Its revenue climbed 7 percent to $4.16 billion. However, analysts were expecting earnings of $0.36 per share on revenue of $3.71 billion. The average estimate among 24 Estimize users was for earnings of $0.38 per share and revenue of $3.76 billion. U.S. revenue declined 3 percent to $1.8 billion in the quarter, while international revenue rose 17 percent. Yervoy sales declined 8 percent to $296 million in the recent quarter. Its gross margin as a percentage of revenues widened to 75.7 percent in the quarter, from 74.5 percent in the year-ago period. Research and development expenses gained 31 percent to $1.9 billion in the quarter, while marketing, selling and administrative expenses rose 2 percent to $968 million. "We had a very good quarter, with strong sales across our portfolio, encouraging results from clinical trials and important regulatory milestones," said Giovanni Caforio, M.D., chief executive officer, Bristol-Myers Squibb. "I am excited by our progress in Immuno-Oncology as we continue to advance our leadership position and transform cancer treatment. As our Immuno-Oncology data continues to emerge, it is clear we have a tremendous opportunity, and we are making the right strategic investments to capitalize on the full potential of our portfolio." For the full year, Bristol-Myers now projects earnings of $1.70 to $1.80 per share, versus its previous outlook of $1.60 to $1.70 per share. Bristol-Myers Squibb shares rose 1.77 percent to $70.60 in pre-market trading.
Loading...
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceprofit
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...